No Data
No Data
No Data
No Data
No Data
2seventy Bio to Report First Quarter 2024 Financial Results on May 8, 2024
2seventy bio, Inc. (NASDAQ:TSVT) will announce its first quarter 2024 financial results on Wednesday, May 8, 2024. A conference call and webcast will be held at 8:00 a.m. ET. Participants can access the conference
BusinesswireMay 3 19:00
Leerink Partners Sticks to Their Buy Rating for 2seventy Bio (TSVT)
TipRanksApr 30 14:06
Bristol-Myers Posts Q1 Beat Despite Growth Headwinds
Seeking AlphaApr 25 19:56
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings—the highest safety-related caution for medications—for all chimeric antige
BenzingaApr 19 21:28
FDA Requires Labeling Changes to CAR-T Cell Therapies to Reflect Cancer Risk
Seeking AlphaApr 19 18:13
2Seventy Bio Said Co, Bristol Myers Squibb Announced That FDA Approved Use Of Suspension Lentiviral Vector For Manufacturing Of Abecma
2Seventy Bio Said Co, Bristol Myers Squibb Announced That FDA Approved Use Of Suspension Lentiviral Vector For Manufacturing Of Abecma
BenzingaApr 9 19:06
No Data
No Data